Biotechnology Focus Podcast

034 | Versant closes oversubscribed sixth healthcare-focused fund

Informações:

Sinopse

Versant Ventures closes its newest fund, a new stem cell company is born in the MaRs Discovery District and Auven Therapeutics official pulls the plug on the KIACTA™ AA amyloidosis program. We have all this and more for you this week on Biotechnology Focus Podcast.